ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$0.12
-0.02 (-15.69%)
As of Aug 29, 2:38 AM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +29,350.8% upside
Low Target $28.98
Average Target $35.93
High Target $50.96
Current Price $0.12
Current
$0.12
Target
$35.93
$28.98 $35.93 avg $50.96
Scenario Analysis
Bear Case
$28.98
23,654.1%
Low target
Base Case
$35.93
+29,350.8%
Avg target
Bull Case
$50.96
+41,670.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.25
-98.5% from high
52-Week Low
$0.09
+40.9% from low
Target vs 52W High
$35.93
+335.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%